Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Auditor change
Appointed director
|
|
IMMUNOMEDICS INC (IMMU)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/23/2020 |
SC 13D/A
| venBio Select Advisor LLC reports a 0% stake in Immunomedics, Inc. |
| 07/01/2019 |
SC 13D/A
| venBio Select Advisor LLC reports a 11% stake in Immunomedics, Inc. |
| 06/19/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/15/2018 |
SC 13D/A
| venBio Select Advisor LLC reports a 9.8% stake in Immunomedics, Inc. |
| 06/05/2018 |
SC 13D/A
| SEATTLE GENETICS INC reports a 4.9% stake in Immunomedics, Inc. |
| 12/06/2017 |
SC 13D/A
| SEATTLE GENETICS INC reports a 7.3% stake in Immunomedics, Inc. |
| 11/15/2017 |
SC 13D/A
| venBio Select Advisor LLC reports a 11.2% stake in Immunomedics, Inc. |
| 05/09/2017 |
SC 13D/A
| venBio Select Advisor LLC reports a 9.9% stake in Immunomedics, Inc. |
| 03/17/2017 |
SC 13D/A
| venBio Select Advisor LLC reports a 9.9% stake in Immunomedics, Inc. |
| 02/15/2017 |
SC 13D/A
| venBio Select Advisor LLC reports a 9.9% stake in Immunomedics, Inc. |
| 09/25/2008 |
SC 13D/A
| GOLDENBERG DAVID M reports a 11.5% stake in Immunomedics, Inc. |
| 08/24/2001 |
SC 13D/A
| GOLDENBERG DAVID M reports a 17.6% stake in Immunomedics, Inc. |
| 05/19/1999 |
SC 13D/A
| GOLDENBERG DAVID M reports a 6.2% stake in IMMUNOMEDICS, INC. |
|
|